Lifeboat Foundation

In this interview, Dr. Leonid Peshkin offers insights on aging, the pitfalls of excessive optimism, and the role of machine learning in studying age-related disease.

Determined but not complacent, grounded but hopeful, Dr. Leonid Peshkin is one of the scientists working on understanding aging so that it may one day be treated like we treat any other ailment.

As he revealed in an interview with the Boston Globe in mid-2018, the idea of having to lose oneself and one’s loved ones to aging never made any sense to him, and ever since he was a child, he has been preoccupied with aging and the fear that it might take away his father, who was almost 60 when Leon was 10 and, sadly, passed away in July 2018 at the age of 96.

Continue reading “An Interview with Dr. Leonid Peshkin” »

The 3 key ingredients for attracting investors to your crowdfunding (ICO/STO) campaign

Below is a redacted and slightly edited and updated version of a memo provided to a client regarding how to attract investors to their business, in mid 2017. For background, they’re a 5 year old private investment firm, whose stock is traded OTC and who invest in startups focused on blockchain tech. To further this model they were exploring additional ways to raise capital, specifically to acquire more startups. Below is a high level framework of what investor “whales” are looking for. This is not investment advice. These are redacted insights into what you should be considering if you’re looking to also engage potential investors in your business enterprise.

If you don’t have time to read it all, I’ll summarize: It still takes money to make money.

Note — all crowdfunding campaigns (regardless of if you call them ICOs / STOs) require a legitimate business model, tangible solutions to real problems, market size worth investing in and the potential for 100x returns. Otherwise, whales aren’t interested in 10x returns.

Continue reading “Magic Whale Formula” »

The same codes needed to thwart errors in quantum computers may also give the fabric of space-time its intrinsic robustness.

Coming soon to a construction site near you…

Radar that can spot stealth aircraft and other quantum innovations could give their militaries a strategic edge.

No one cared who I was until I put on the mask (and my skin cleared up.)

SocialRecall says it deletes obsolete user data on the event version of the app, and that data for the other version is only stored on a user’s phone.

But privacy experts are still concerned that the app represents a mainstream rollout of technology that could have profound implications for the future of public spaces — and that it’s difficult to adequately inform users about the long-term risks of a technology that’s still so new.

“The cost to everyone whom you are surveilling with this app is very, very high,” New York University law professor Jason Schultz told Scientific American, “and I don’t think it respects the consent politics involved with capturing people’s images.”

We had no shortage of blood pressure medication recalls in 2018, with multiple companies issuing warnings over drug impurities that could cause cancer. It looks like that trend will continue in 2019 as yet another company has issued a recall of blood pressure tablets after detecting an impurity that may be cancer-causing.

This time around it’s Aurobindo Pharma USA Inc, which is recalling prescriptions of the drug Valsartan, you may remember, has been the subject of recalls due to such impurities in the past. The drug is sold by several manufacturers, and in July of 2018 almost a half-dozen companies were forced to recall their products due to the discovery of human carcinogens in the tablets.

The iPhone isn’t selling as well as Apple expected. Tim Cook blames China’s cooling-down economy, but a lot of users say it’s because the phone are too expensive for the features they offer.

Apple shares plummeted after CEO Tim Cook revealed that the iPhone maker expects a drop of up to $9bn in revenue compared to its November report. More affordable battery replacements are to blame, among other things.

Apple stated that it now expects a revenue of approximately $84 billion in the first quarter of 2019, down from its previous estimate of $89bn to $93bn. Markets have reacted swiftly to the news, sending Apple shares into a 7.5-percent nosedive.

Continue reading “Apple iPhone sales look $9bn worse than expected, CEO blames China & cheap batteries” »